Part 18/19:
The convergence of security, economic, and health concerns underscores the importance of a comprehensive US strategy to reduce dependency on foreign pharmaceuticals. This includes:
Expanding domestic manufacturing capacity for generic and essential medicines.
Building strategic reserves of critical drugs.
Reassessing trade and supply chain policies to incentivize US-based production.
Strengthening international collaborations with allied nations to diversify supply sources.
In conclusion, whether it’s combating cartel violence, redefining trade policies, or ensuring pharmaceutical independence, the overarching message is clear: strategic, robust, and proactive policies are essential for safeguarding US national security and economic vitality.